BETTERLIFE PHARMA INC. Research And Development Expense
BETTERLIFE PHARMA INC. (BETRF) reported Research And Development Expense of CAD 424.34 thousand for the 12-month period ending 2025-01-31, per its 20-F filed 2025-06-02.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2025-06-02
| Period end | Research And Development Expense 12 month |
|---|---|
| 2025-01-31 | 424.34K CAD 20-F · filed 2025-06-02 |
| 2024-01-31 | 570.95K CAD 20-F · filed 2025-06-02 |
| 2023-01-31 | 2.68M CAD 20-F · filed 2025-06-02 |
| 2022-01-31 | 5.42M CAD 20-F · filed 2024-05-30 |
| 2021-01-31 | 284.70K CAD 20-F/A · filed 2023-06-06 |
| 2020-01-31 | 63.77K CAD 20-F · filed 2022-06-06 |
| 2019-01-31 | 364.78K CAD 20-F/A · filed 2021-06-23 |